You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • FRI0126 Characterization of Patients' Adherence and Persistence Profile (“Drug Survival”) in a “Real Life” Population of Patients Treated with Adalilumab

Article info

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
FRI0126 Characterization of Patients' Adherence and Persistence Profile (“Drug Survival”) in a “Real Life” Population of Patients Treated with Adalilumab

Authors

Citation

Gendelman O, Shalev V, Dahlia Weitzman D, et al
FRI0126 Characterization of Patients' Adherence and Persistence Profile (“Drug Survival”) in a “Real Life” Population of Patients Treated with Adalilumab
Annals of the Rheumatic Diseases 2015;74:466.

Publication history

  • First published June 9, 2015.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions